Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry
Completed
- Conditions
- Stable AnginaNSTEMI - Non-ST Segment Elevation MIUnstable AnginaSTEMIACS - Acute Coronary SyndromeMyocardial Infarction
- First Posted Date
- 2017-04-06
- Last Posted Date
- 2018-08-07
- Lead Sponsor
- CeloNova BioSciences, Inc.
- Target Recruit Count
- 1027
- Registration Number
- NCT03103620
- Locations
- 🇫🇷
SCM Angioscan, Antony, France
🇫🇷Clinique Axium, Aix, France
🇫🇷GCS Cardio, Annecy, France
Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy
Not Applicable
- Conditions
- Angina, StableAnticoagulantsAngina, Unstable
- Interventions
- Device: Drug Eluting StentDevice: COBRA PzF
- First Posted Date
- 2015-11-03
- Last Posted Date
- 2020-10-26
- Lead Sponsor
- CeloNova BioSciences, Inc.
- Target Recruit Count
- 996
- Registration Number
- NCT02594501
- Locations
- 🇫🇷
Clinique du Millénaire, Montpellier, France
🇩🇪University of Jena, Jena, Germany
🇺🇸Christiana Care Health Services, Newark, Delaware, United States
COBRA SHIELD OCT Study
Not Applicable
Terminated
- Conditions
- Stable Angina
- Interventions
- First Posted Date
- 2014-08-25
- Last Posted Date
- 2020-10-06
- Lead Sponsor
- CeloNova BioSciences, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT02224235
- Locations
- 🇫🇮
Heart Center, Turku University Hospital, Turku, Finland
🇫🇮Satakunta Central Hospital, Pori, Finland
COBRA PZFâ„¢ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT
Not Applicable
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: COBRA PzF
- First Posted Date
- 2013-08-20
- Last Posted Date
- 2021-12-22
- Lead Sponsor
- CeloNova BioSciences, Inc.
- Target Recruit Count
- 296
- Registration Number
- NCT01925794
- Locations
- 🇺🇸
Mt Sinai Medical Center, Miami Beach, Florida, United States
🇺🇸Emory University Hospital, Atlanta, Georgia, United States
🇺🇸Heart Center of Indiana, Indianapolis, Indiana, United States
REVEAL Study: Vessel Healing After Angioplasty
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Catania Stent
- First Posted Date
- 2008-11-27
- Last Posted Date
- 2014-01-16
- Lead Sponsor
- CeloNova BioSciences, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT00799344
- Locations
- 🇮🇹
Ferrarotto Hospital, Catania, Sicily, Italy
The ATLANTA First in Man Study of the Catania Stent
Phase 1
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: PCI
- First Posted Date
- 2008-11-27
- Last Posted Date
- 2017-06-07
- Lead Sponsor
- CeloNova BioSciences, Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT00799032
- Locations
- 🇮🇹
Ferrarotto Hospital, Catania, Sicily, Italy
© Copyright 2025. All Rights Reserved by MedPath